La chaîne d'options affiche les données clés des options sur actions de Climb Bio à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Climb Bio..

Climb Bio (NASDAQ:CLYM) Stock, Chaîne d'Options

CLIMB BIO INC

Climb Bio

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.

Climb Bio Inc

Earnings

Press Releases

Climb Bio Reports First Quarter 2025 Financial Results and Provides Business Updates

Health Care

Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

News

Management

Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer

Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates

Climb Bio to Present at Upcoming September 2025 Investor Conferences

UPDATE – Climb Bio to Present at Upcoming September 2025 Investor Conferences

General

Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025

Penny Stocks

Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN

Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer

Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025

CLYM

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals

Alpha Cognition

Agenus

Anika Therapeutics

Anixa Biosciences

Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals

Atossa Therapeutics

Cardiff Oncology

Forte Biosciences

Greenwich LifeSciences, Inc. - Common stock

Greenwich LifeSciences

TuHURA Biosciences

Insight Molecular Diagnostics Inc. - Common Stock

Insight Molecular

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

Opus Genetics

Metagenomi

Molecular Partners AG - American Depositary Shares

Molecular Partners

Oncolytics Biotech

AVITA Medical

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics

Spero Therapeutics

TScan Therapeutics

Instil Bio

Tevogen Bio Holdings

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics

Whitehawk Therapeutics, Inc. - Common Stock

Whitehawk Therapeutics

BTIG

HC Wainwright & Co.

Baird

Oppenheimer

Comments

Climb Bio

Climb Bio (CLYM) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL